Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.…
Respilean Drops Exposed (MUST-READ): The Truth About Lung Support Big Pharma Doesnt Want You to Know
JUPITER, FLORIDA, April 02, 2025 (GLOBE NEWSWIRE) -- RESPILEAN In a world…
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025
March 31, 2025 17:00 ET | Source: Zealand Pharma Company announcement –…
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
Company presented clinical and preclinical data at the MDA Conference last week…
Azurity Pharmaceuticals Completes Acquisition of Covis Pharma
WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful…
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ -- Laminar Pharma, a leader…
Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives
SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc.…
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
February 28, 2025 02:42 ET | Source: Nxera Pharma Daridorexant is a…
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
February 27, 2025 19:05 ET | Source: Nxera Pharma Cenerimod is a…
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 07, 2025 16:01 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, the…